Page 4 - Pharnext Share News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Pharnext share. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Pharnext Share Today - Breaking & Trending Today

PHARNEXT: New study published by Edison Investment Research updates valuation of Pharnext's assets

PARIS, France, March 7th, 2023, 08:30 am CET - Pharnext SCA (FR001400BV89 - ALPHA) (the "Company"), an advanced late-clinical stage biopharmaceutical company developing novel therapeutics for neurodegenerative ....

United States , France General , Dennis Riedl , Mary Jane Elliott , Fabreguettes Leib , Deborah Schwartz , Hugo Brugi , Alexandra Harrison , Sukaina Virji , Financial Press Relations , Relations International , Edison Investment Research , Consilium Strategic Communications , Euronext Growth ,

PHARNEXT: Pharnext supports and participates in the 27th edition of the Francophone Peripheral Nerve Society conference (SFNP) in Paris

PARIS, France, March 6th, 2023, 08:30 am CET - Pharnext SCA (FR001400BV89 - ALPHA) (the "Company"), an advanced late-clinical stage biopharmaceutical company developing novel therapeutics for neurodegenerative ....

United States , France General , Dennis Riedl , Mary Jane Elliott , Fabreguettes Leib , Deborah Schwartz , Alexandra Harrison , Sukaina Virji , Financial Press Relations , Relations International , Francophone Peripheral Nerve Society , Consilium Strategic Communications , Euronext Growth ,

PHARNEXT: Pharnext refocuses its clinical trial programs on PXT3003, its most promising drug candidate, to optimize financial resources allocation

PARIS, France, February 14th, 2023, 08:30 am CET - Pharnext SA (FR001400BV89 - ALPHA) (the "Company"), an advanced late-clinical stage biopharmaceutical company developing novel therapeutics for neurodegenerative ....

United States , France General , Dennis Riedl , Mary Jane Elliott , Fabreguettes Leib , Deborah Schwartz , Hugo Brugi , Alexandra Harrison , Sukaina Virji , Financial Press Relations , Relations International , Company Board Of Directors , Consilium Strategic Communications , Amyotrophic Lateral Sclerosis , Euronext Growth , Neuroscience Res ,

PHARNEXT: Pharnext unveils the latest progress of the PREMIER trial, pivotal Phase III clinical trial of PXT3003 in Charcot-Marie-Tooth disease type 1A

PARIS, France, February 2nd, 2023, 08:30 am CET - Pharnext SA (FR001400BV89 - ALPHA) (the "Company"), an advanced late-clinical stage biopharmaceutical company developing novel therapeutics for neurodegenerative ....

United States , France General , Baden Wüberg , Deborah Schwarz , Mary Jane Elliott , Fabreguettes Leib , Alexandra Harrison , Sukaina Virji , Schwierige Zeiten , Financial Press Relations , Relations International , Euronext Growth Stock Exchange , Clinical Development Program , Consilium Strategic Communications , Overall Neuropathy Limitations Scale , Open Label Extension , Chief Medical Officer , Charcot Marie Tooth Disease Type , Meter Walk Test , Quantified Muscular Testing , Patient Global Impression , Charcot Marie Tooth Neuropathy Score , Announces First Patient Enrolled , Pivotal Phase , Development Program , Announces On Schedule Completion ,

PHARNEXT: Pharnext announces successful completion of manufacturing transfer and scale-up of PXT3003 in the United States

Pharnext announces successful completion of manufacturing transfer and scale - up of PXT3003 in the United States
PARIS, France, January 26th, 2023, 08:30 am CET - Pharnext SA (FR001400BV89 - ALPHA) ....

New York , United States , France General , Unither Colomiers , Unither Rochester , Mary Jane Elliott , Fabreguettes Leib , Alexandra Harrison , Sukaina Virji , Raj Thota , Euronext Growth Stock Exchange , Media Relations International , Consilium Strategic Communications , Chief Manufacturing Officer , Presse Financi ,